ESC 365 - Mutant KCNJ3 and KCNJ5 potassium channels as novel molecular targets in bradyarrhythmias and atrial fibrillation.

ESC Premium Access

Mutant KCNJ3 and KCNJ5 potassium channels as novel molecular targets in bradyarrhythmias and atrial fibrillation.

Session: Translating Basic Science Discoveries into Clinical Practice

Topic: Basic Science, Other

Speaker: Doctor N. Yamada (Suita, JP)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Noriaki Yamada

Osaka University Graduate School of Medicine, Suita (Japan)

1 presentation

0 follower

3 more presentations in this session

Dietary spermidine: a story of cardioprotection and longevity.

Speaker: Doctor M. Abdellatif (Graz, AT)

A novel anti-arrhythmic drug: the TASK-1 channel tale.

Speaker: Professor C. Schmidt (Heidelberg, DE)

Activation of invariant natural killer T cells for heart failure therapy.

Speaker: Doctor M. Ikeda (Fukuoka, JP)

Access the full session

Translating Basic Science Discoveries into Clinical Practice

Speakers: Doctor N. Yamada, Doctor M. Abdellatif, Professor C. Schmidt, Doctor M. Ikeda

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources